Das klinische Spektrum der Dermatomyositis. The clinical spectrum of dermatomyositis
Authors:
- 1 March 2005
- journal article
- research article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 3 (3) , 181-194
Abstract
Dermatomyositis is characterized by marked clinical heterogeneity. Many classification schemes are available, based on internal organ involvement, presence of circulating autoantibodies and additional symptoms characteristic for other connective tissue diseases. Viral infections and underlying malignancies are possible mechanisms to trigger this autoimmune disease. Intensive clinical investigations to detect such malignancies are therefore required. The prognosis of the individual patient depends on the involvement of internal organs and the characterization of circulating autoantibodies. There are patients with rapidly developing subsets of dermatomyositis and those with slowly progressive disease. Therefore treatment has to be adjusted for the disease severity. Sometimes high dosages of corticosteroids in combination with immunosuppressive agents or immunoglobulins are required.Keywords
This publication has 51 references indexed in Scilit:
- Therapeutic Approaches in Patients with Inflammatory MyopathiesSeminars in Neurology, 2003
- Anisotropy of the energy gap in the insulating phase of the U-t-t' Hubbard modelThe European Physical Journal B, 2000
- Drug-induced myopathiesCurrent Opinion in Neurology, 2000
- Autoantibodies in Inflammatory MyopathiesThe American Journal of the Medical Sciences, 2000
- DermatomyositisJournal of the American Academy of Dermatology, 1998
- Strong association of dermatomyositis‐specific Mi‐2 autoantibodies with a tryptophan at position 9 of the HLA‐DRβ chainArthritis & Rheumatism, 1996
- Risk of Cancer in Patients with Dermatomyositis or PolymyositisNew England Journal of Medicine, 1992
- A New Approach to the Classification of Idiopathic Inflammatory MyopathyMedicine, 1991
- Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus.Journal of Experimental Medicine, 1990
- Juvenile dermatomyositis treated with cyclosporineJournal of the American Academy of Dermatology, 1990